Main > PHARMA. > Patent. > Expiration Dates>USA> > Year 2019 > Endo>Diabetes>TesaGlitazar

Product UK. A

INDICATION'S - Metabolic Syndrome
MECHANISM OF ACTION - Insulin Sensitizer
- PPAR Alpha & Gamma Agonist
STATUS Phase III
UPDATE 07.05
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free
TRADEMARK This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back